1. Home
  2. VABK vs VNDA Comparison

VABK vs VNDA Comparison

Compare VABK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$50.44

Market Cap

265.4M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$4.04

Market Cap

301.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
VNDA
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.4M
301.1M
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
VABK
VNDA
Price
$50.44
$4.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $11.75
AVG Volume (30 Days)
8.0K
★ 818.4K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
★ 2.88%
N/A
EPS Growth
★ 12.70
N/A
EPS
★ 2.62
N/A
Revenue
N/A
★ $216,105,000.00
Revenue This Year
N/A
$15.16
Revenue Next Year
N/A
$35.50
P/E Ratio
$19.10
★ N/A
Revenue Growth
N/A
★ 8.72
52 Week Low
$37.35
$3.96
52 Week High
$52.69
$9.91

Technical Indicators

Market Signals
Indicator
VABK
VNDA
Relative Strength Index (RSI) 57.90 26.58
Support Level $46.42 N/A
Resistance Level N/A $5.37
Average True Range (ATR) 1.33 0.18
MACD -0.00 -0.03
Stochastic Oscillator 54.71 8.82

Price Performance

Historical Comparison
VABK
VNDA

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: